EWT vs XBI
iShares MSCI Taiwan ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.59% for EWT.
- • EWT pays a higher dividend yield (0.92%).
Side-by-side metrics
| Metric | EWT | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.92% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $11.15B | $10.73B |
YTD return | 63.54% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.24 | 1.10 |
P/E ratio | 29.38 | — |
Last price | $105.51 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
EWT top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 20.74% |
| 2454.TW | MediaTek Inc | 6.62% |
| 2308.TW | Delta Electronics Inc | 4.26% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 3.39% |
| 2327.TW | Yageo Corp | 3.20% |
| 3711.TW | ASE Technology Holding Co Ltd | 3.08% |
| 2303.TW | United Microelectronics Corp | 2.50% |
| 3037.TW | Unimicron Technology Corp | 2.39% |
| 2383.TW | Elite Material Co Ltd | 2.38% |
| 2345.TW | Accton Technology Corp | 2.01% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EWT
EWT (iShares MSCI Taiwan ETF) is Taiwanese large- and mid-cap equities. Managed by iShares, the fund carries $11.2B in assets under management, an expense ratio of 0.59%, a dividend yield of 0.92%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 20.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.